Wolfram Bode

发表

Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7

Manfred Schmitt, C. Craik, W. Bode, 2008, Biological chemistry.

Crystal structure of uninhibited factor VIIa

Robert Huber, Karl-Peter Hopfner, Wolfram Bode, 2002 .

Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases

W. Bode, K. Maskos, Wolfram Bode, 2003, Molecular biotechnology.

(R)-3-Amidinophenylalanine-Derived Inhibitors of Factor Xa with a Novel Active-Site Binding Mode

Luis Moroder, W. Bode, S. Sperl, 2002, Biological chemistry.

Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex

Robert Huber, R. Huber, W. Bode, 2000, Nature.

Structure and interaction modes of thrombin.

W. Bode, Wolfram Bode, 2006, Blood cells, molecules & diseases.

Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2

Francesc X. Avilés, Robert Huber, Josep Vendrell, 2000, Nature Structural Biology.

Catalytic Domain Structures of MT-SP1/Matriptase, a Matrix-degrading Transmembrane Serine Proteinase*

Robert Huber, R. Huber, W. Bode, 2002, The Journal of Biological Chemistry.

Thrombin inhibitors identified by computer-assisted multiparameter design.

Andreas Schwienhorst, Michael Gebinoga, Martin Wiesenfeldt, 2005, Proceedings of the National Academy of Sciences of the United States of America.

The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis Structural analysis, subtilisin structure and interface geometry

Djordje Musil, W. Bode, E. Papamokos, 1987 .

The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism

Robert Huber, Hans-Ulrich Demuth, Ulrich Heiser, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Ligand binding: proteinase-protein inhibitor interactions

Robert Huber, R. Huber, W. Bode, 1991 .

The 1.9-Å crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link

Robert Huber, Hans D. Bartunik, R. Huber, 2002, Proceedings of the National Academy of Sciences of the United States of America.

The crystal structure of the proprotein processing proteinase furin explains its stringent specificity

Robert Huber, Angus Cameron, R. Huber, 2003, Nature Structural Biology.

Crystal structures of thrombin and thrombin complexes as a framework for antithrombotic drug design

W. Bode, M. Stubbs, Wolfram Bode, 1994 .

1.2 A crystal structure of the serine carboxyl proteinase pro-kumamolisin; structure of an intact pro-subtilase.

Robert Huber, Kohei Oda, Hiroshi Oyama, 2004, Structure.

The metzincins — Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc‐peptidases

P. Reinemer, U. Baumann, W. Bode, 1995, Protein science : a publication of the Protein Society.

X-ray structure of isoaspartyl dipeptidase from E.coli: a dinuclear zinc peptidase evolved from amidohydrolases.

Robert Huber, R. Huber, W. Bode, 2003, Journal of molecular biology.

On the disordered activation domain in trypsinogen: chemical labelling and low‐temperature crystallography

Robert Huber, R. Huber, J. Walter, 1982 .

Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.

Robert Huber, R. Huber, W. Bode, 2007, Journal of molecular biology.

X-ray Structure of Active Site-inhibited Clotting Factor Xa

Robert Huber, Richard A. Engh, R. Huber, 1996, The Journal of Biological Chemistry.